Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1287623 Target Snapshot

Lethal(3)malignant brain tumor-like protein 3 · SINGLE PROTEIN · Homo sapiens

126Compounds
50Assays
1Approved Drugs
226.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q96JM7. Use UniProt Q96JM7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q96JM7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lethal(3)malignant brain tumor-like protein 3 as ChEMBL target CHEMBL1287623, mapped to UniProt Q96JM7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lethal(3)malignant brain tumor-like protein 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1287623
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q96JM7
Lethal(3)malignant brain tumor-like protein 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lethal(3)malignant brain tumor-like protein 3 is the right protein anchor across sources, using UniProt Q96JM7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLethal(3)malignant brain tumor-like protein 3
UniProt AccessionQ96JM7
Component TypeProtein
Sequence Length780 aa

Lethal(3)malignant brain tumor-like protein 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lethal(3)malignant brain tumor-like protein 3, mapped to UniProt Q96JM7. Sequence length is 780 aa.

Mapped IDQ96JM7
Review nameLethal(3)malignant brain tumor-like protein 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50193.0
KD33.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2426364 7.62 IC50 24.0 Preclinical
CHEMBL3134130 7.43 IC50 37.0 Preclinical
CHEMBL2426365 7.41 IC50 39.0 Preclinical
CHEMBL2426360 7.37 IC50 43.0 Preclinical
CHEMBL2426366 7.32 IC50 48.0 Preclinical
CHEMBL2426498 7.32 IC50 48.0 Preclinical
CHEMBL3134144 7.32 IC50 48.0 Preclinical
CHEMBL2426367 7.28 IC50 53.0 Preclinical
CHEMBL3134146 7.23 IC50 59.0 Preclinical
CHEMBL2424678 7.21 IC50 61.0 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
25
5.5
37
6.0
51
6.5
36
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

50
Total Assays
103
Tested Compounds
2
Assay Types
Binding — 49 assays, 103 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 35 102 6.3
cell-based format 13 1 6.8
subcellular format 1 0
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine